Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

Italy levies eye-opening antitrust fines against Roche, Novartis over Lucentis

05.03.2014 / Fierce Pharma

Doctors have been prescribing Roche&#39;s cancer drug Avastin off-label to treat some of the same vision problems as its eye drug, Lucentis. Now, Italy&#39;s antitrust authority has fined Roche and marketing partner Novartis,<span style="font-size: 13px;">&nbsp;accusing them of colluding to push doctors toward the pricier option–claims the pair denies.</span>

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: